An observational study in Child Development, Child Development Disorder and Development Delay, sponsored by Universitas Indonesia. Completed at 1 site in Indonesia. Open to participants aged 23 Months to 38 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-06-09.
Sponsored by Universitas Indonesia · Observational
This study aimed to evaluate the concurrent validity information of the 24-, 30-, and 36-month Indonesian ASQ-3 with the Bayley Scales of Infant and Toddler Development 3rd Edition (BSID-III) in Indonesian children. Children living in Tanah Tinggi subdistrict, Central Jakarta, were recruited conveniently from November to December 2019. Children within the 24-, 30-, or 36-month age group were assessed for Indonesian ASQ-3 concurrently with BSID-III as the reference standard according to their age groups. Screening test accuracy was measured in sensitivity, specificity, and predictive values for both overall dan specific domains.
291 studies on the registry are indexed under Developmental Disabilities; 65 are open to participants now.
This study's enrollment of 131 is below the median of 150 across 83 observational studies indexed under Developmental Disabilities.
Browse Developmental Disabilities studies →Universitas Indonesia is the lead sponsor of 29 studies on the registry; 12 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Parents with children aged 23-38 months living in Central Jakarta.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Child development
Measured once with Indonesian Ages and Stages-3 questionnaire (cross sectional study) with scores ranging between 0 to 60 per domain. Higher score means better development.
Time frame: Day 1
Child development
Measured once with Bayley Scales Infant Development-III with scores ranging between 40 to 160 per domain. Higher score means better development.
Time frame: Day 1
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Nov 2019 to primary completion in Dec 2019, 1 month.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universitas Indonesia